Article Versions Notes

Elsawalhy M, Abdel-Rahman AA-H, Basiony EA, Ellithy SA, Hassan AA, Abou-Amra ES, Ismail A, Almehizia AA, Al-Omar MA, Naglah AM, et al. Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer’s Disease. Pharmaceuticals. 2024; 17(10):1407. https://doi.org/10.3390/ph17101407

Elsawalhy, Mohamed, Adel A-H Abdel-Rahman, Ebtesam A. Basiony, Salma A. Ellithy, Allam A. Hassan, Eman S. Abou-Amra, Abdelhamid Ismail, Abdulrahman A. Almehizia, Mohamed A. Al-Omar, Ahmed M. Naglah, and et al. 2024. "Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer’s Disease" Pharmaceuticals 17, no. 10: 1407. https://doi.org/10.3390/ph17101407

Elsawalhy, M., Abdel-Rahman, A. A.-H., Basiony, E. A., Ellithy, S. A., Hassan, A. A., Abou-Amra, E. S., Ismail, A., Almehizia, A. A., Al-Omar, M. A., Naglah, A. M., & Hassan, N. A. (2024). Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer’s Disease. Pharmaceuticals, 17(10), 1407. https://doi.org/10.3390/ph17101407